预测癌症患者生命末期风险:一个多中心队列研究
Lu Peng1, Yixuan Wang1, Wenzhi Zhao1
1Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Science progress
|November 6, 2025
概括
识别生命末期 (EOL) 癌症患者至关重要. 机器学习识别了关键的风险因素,如营养不良和晚期,改善了EOL癌症的治疗和预后.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 医疗保健中的机器学习
背景情况:
- 管理生命末期 (EOL) 癌症患者带来了重大的医疗保健挑战.
- 个性化EOL治疗和避免过度治疗至关重要,但准确识别EOL患者仍然很困难.
研究的目的:
- 使用机器学习分析EOL癌症患者的特征.
- 确定与癌症患者EOL风险相关的关键决定因素.
- 开发EOL风险的预测模型.
主要方法:
- 使用了常见癌症的营养状况和临床结果 (INSCOC) 队列.
- 采用机器学习技术,包括后勤回归 (LR),支持矢量机器和随机森林.
- 使用可归因于人口的分数和最小绝对收缩和选择操作员回归分析的选预测指标.
主要成果:
- 分析了17013名患者,1109人被确定为EOL.
- 后勤回归 (LR) 成为表现最好的模型.
- EOL风险的关键决定因素包括晚期,中性粒细胞与淋巴细胞的比例,营养不良,低albuminemia,糟糕的自我健康评估,有限的运动能力,预后营养指数,食欲不足和癌症的位置.
结论:
- 研究结果为精确管理EOL癌症患者提供了宝贵的见解.
- 及时识别和干预风险因素可能会降低EOL风险.
- 改进的识别和管理可以使EOL癌症患者的预后更好.
更多相关视频
相关概念视频
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Kaplan-Meier Approach
547
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
547
Actuarial Approach
281
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
281
Comparing the Survival Analysis of Two or More Groups
542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542
Assumptions of Survival Analysis
388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388


